Examples | Mayo Clinic Business Development

Examples of our work

Collaborations, business transactions, agreements & start-ups

From joining forces with established entities to emerging start-ups, we collaborate across the spectrum to bring disruptive healthcare technologies and novel business ventures to life for the benefit of patients everywhere.

Below is a small sampling.

Mayo Clinic entered into a collaboration with Adaptive Phage Therapeutics, a clinical-stage biotechnology company, to conduct a clinical trial using PhageBank™ investigational therapy to address the need for alternative treatments for chronic infections following joint replacement.

Anumana, an AI-driven company born from nference and Mayo Clinic, is working to create and bring to market innovative digital sensor diagnostics by applying nference’s AI to Mayo Clinic's deep repository of medical data, providing early diagnosis and intervention to patients.

Mayo Clinic and W. L. Gore & Associates Inc., a global materials science company, formed a strategic collaboration to advance the development of implantable cell therapies to treat debilitating conditions that have no cure. Avobis Bio - the strategic collaboration - combines Mayo Clinic's clinical and cell expertise and Gore's expertise in material sciences to address some of the most challenging medical issues.

Mayo Clinic entered into a collaboration with BioSig Technologies, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, to develop a next-generation AI- and machine learning-powered software for its PURE EP™ system.

Collaborative Robotics team launched the Cobot Flywheel Program to help the world's most innovative companies in biotech, healthcare, and logistics drive operational transformation with advanced robotics solutions. As part of its collaboration with Collaborative Robotics, Mayo Clinic has adopted the Cobot Flywheel Program to accelerate robotics initiatives.

Mayo Clinic and Google announced a 10-year strategic partnership in September 2019 to redefine how healthcare is delivered and accelerate the pace of healthcare innovation through digital technologies. Mayo Clinic will transform the way it advances virtual care with AI-enabled digital diagnostics and will leverage Google technology to boost its ability to conduct medical research.

Marani Health, an AI-powered platform for remote pregnancy care co-founded by Mayo Clinic, was created to address the need of capturing critical fetal biometric data and remote monitoring of pregnant women at home.

Mayo Clinic selected Medically Home, a Boston-based technology-enabled services company, as its implementation partner for a new care model for delivering innovative, comprehensive, and complex care to patients from the comfort of home. Through this initiative, patients with conditions previously managed in a hospital have the option to transition to a home setting and receive compassionate, high-quality virtual and in-person care and recovery services.

Mayo Clinic entered into a know-how license agreement with MediView XR Inc., a clinical augmented reality (AR) med-tech company, to advance procedural AR solutions, specifically for surgical procedures in non-fixed, soft tissue/organ or bone planning, navigation or assistance.

Moat Biotechnology is a clinical stage company focused on the development of novel intranasal and oral vaccines based on a platform (SC-AdVax) exclusively licensed from Mayo Clinic.

Mayo Clinic selected nference, a Cambridge-based AI company, to provide de-identification capabilities and to serve as a Platform partner to focus on identifying targets for new drugs or new indications for existing drugs. This initiative seeks to accelerate new treatments for diseases and will optimize clinical trials. nference will combine its proprietary knowledge synthesis platform with the clinical expertise of Mayo Clinic physicians and scientists.

Mayo Clinic collaborated with venture capital firm Eclipse Ventures to found Nucleus RadioPharma, a new company (CDMO) built to ensure cancer patients can access potentially lifesaving radiopharmaceuticals.

Perspective Therapeutics has entered into a patent license agreement with Mayo Clinic for the rights to the PSMA Alpha-PET DoubLET platform technology for the treatment of PSMA-expressing cancers, with an initial focus on prostate.

Mayo Clinic entered into an agreement with Theator, a leader in surgical video AI, to utilize its surgical intelligence platform for surgery preparation, performance, and review using contextual insights while maintaining patient privacy. This includes analysis and feedback for intraoperative events, situational awareness, decision-support, competency assessment, teaching moments, and comparative analytics.

Unity Biotechnology, a start-up cofounded by Mayo Clinic, is developing a new class of therapeutics intended to selectively eliminate or modulate senescent cells to halt, slow or reverse age-related disease and restore tissue to a more functionally healthy state.

Content displayed is subject to change.